1 completed, 1 unknown. 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Unknown 1 |
| Phase 3 | 1 | Completed 1 |
Follow ansuvimab: new trials by email Literature Review of ansuvimab trials Research Report on ansuvimab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Prophylaxis Vaccine Antibodies Ebola ansuvimab, Ervebo - Ebola Virus Disease | Phase 2 | Unknown | ANRS, Emerging Infectious Diseases | 250 | 2021-10-17 | 2021-10-15 |
| Investigational Therapeutics for the Treatment of People With Ebola Virus Disease ZMapp, Remdesivir, MAb114 - Ebola Virus | Phase 2 / Phase 3 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 681 | 2018-11-21 | 2021-09-08 |
Hemorrhagic Fever, Ebola (1) · Hemorrhagic Fevers, Viral (1)
ANRS, Emerging Infectious Diseases (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1)
Democratic Republic of the Congo (1) · Guinea (1) · United States (1)